Cite
HARVARD Citation
Koyama, A. et al. (2015). Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled, phase II dose finding trial. BMC nephrology. 16 (1), pp. 1-15. [Online].